Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.91 -0.03 (-3.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2023)

Bluejay Diagnostics (BJDX) posted Amortizatization of Intangibles of $40327.0 for Q2 2023, little changed sequentially from $40328.0 in Q1 2023, and up 4.11% YoY from $38734.0 in Q2 2022.

Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2023) Analysis & Trends

Bluejay Diagnostics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $40327.0 in Q2 2023.

  • Quarterly Amortizatization of Intangibles rose 4.11% year-over-year to $40327.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $147627.0 (up 363.78% YoY) and the FY2022 annual result came in at $145837.0, up 536.87% from the prior year.
  • Amortizatization of Intangibles was little changed at $40327.0 in Q2 2023 per BJDX's latest filing, from $40328.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $40328.0 in Q1 2023 and troughed at -$122938.0 in Q4 2021.
  • A 4-year average of -$2189.6 and a median of $29167.0 in 2020 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2021 and 2023: Amortizatization of Intangibles sank 77.7% in 2021, then jumped 42.81% in 2023.
  • Over 4 years, Amortizatization of Intangibles stood at -$69183.0 in 2020, then plunged by 77.7% to -$122938.0 in 2021, then jumped by 131.51% to $38734.0 in 2022, then gained by 4.11% to $40327.0 in 2023.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $40327.0, $40328.0, and $38734.0 for Q2 2023, Q1 2023, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 6.60 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Bluejay Diagnostics 1.89 Mn 1.89 Mn - 22,204.00

Historic Data

Download Data
DateValue
Jun 30, 2023 40,327.00
Jun 30, 2023 40,327.00
Mar 31, 2023 40,328.00
Mar 31, 2023 40,328.00
Jun 30, 2022 38,734.00
Jun 30, 2022 38,734.00
Mar 31, 2022 28,238.00
Mar 31, 2022 28,238.00
Dec 31, 2021 -122,938.00
Dec 31, 2021 -122,938.00
Dec 31, 2020 -69,183.00
Dec 31, 2020 -69,183.00
Sep 30, 2020 29,167.00
Sep 30, 2020 29,167.00